Study to assess hair growth

A pilot study to evaluate the safety and efficacy of serums in improving hair growth in female subjects - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064879

Enrollment

Registered

2024-03-28

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: HS-1: 1ml of HS-1 will be applied twice daily for 12 weeks Intervention2: HS-2: 1ml of HS-2 will be applied twice daily for 12 weeks Control Intervention1: HS-3: 1ml of HS-3 will be

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects complaining of hair fall and damage. 2.Subjects willing to give a written informed consent and willing to abide by and comply with the study protocol. 3.Hair density of less than 100 and more than 200 hair follicle per square cm as per TrichoScan measurement 4.Female Subjects falling under Grade 3 - Grade 6 of hair loss severity grade evaluated as per MSCR photo numerical 10-point scale

Exclusion criteria

Exclusion criteria: 1 Subjects who have undergone any kind of hair growth treatment in the last 3 months 2 Subjects having any active but controllable scalp disease which may interfere in the study assessments 3 Subjects who have taken chemotherapy for cancer in the 6 months prior to the studys start 4 Subjects who have history of crash dieting and or psychiatric disorder including trichotillomania 5 Subjects who have undergone hair transplant 6 A known history or present condition of allergic response or hypersensitivity to any topical or oral cosmetic pharmaceutical or nutraceutical product 7 Subjects on oral medications like topical or systemic corticosteroids undergoing any chemical hair salon treatment which will compromise the study 8 Subjects with chronic illness which may influence the cutaneous state 9 Subjects who are pregnant or nursing Self declared 10 Subjects with any history or present of underlying uncontrolled medical illness or any other serious medical illness

Design outcomes

Primary

Measure	Time frame
To evaluate and compare hair growth, thickness, reduction in hair fall after use of the test products in comparison to baseline and all time points by dermatological and instrumental assessments.Timepoint: Baseline, Week 2, Week 4, Week 8, Week 12	—

Secondary

Measure	Time frame
NATimepoint: NA	—

Countries

India

Contacts

Public ContactDr Mukesh Ramnane

M S Clinical Research

mukesh.ramnane@msclinical.com08040917253

Outcome results